2 weeks Ago By Defense World Staff
Surgery Partners, Inc. ( NASDAQ:SGRY – Get Free Report ) has earned an average recommendation of “Moderate Buy” from the seven analysts that are covering the stock, MarketBeat.com reports.
One research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $39.86.
SGRY has been the subject of a number of recent research reports. Citigroup cut their price objective on shares of Surgery Partners from $38.00 to $36.
00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Cantor Fitzgerald reissued an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research report on Monday, August 19th.
Royal Bank of Canada reaffirmed an “outperform” rating and issued a $49.00 price objective on shares of Surgery Partners in a report on Wednesday, August 7th. Macquarie initiated coverage on Surgery Partners in a report on Friday, June 28th.
They set an “outperform” rating and a $31.00 target price on the stock. Finally, Benchmark restated a “buy” rating and issued a $50.
00 price target on shares of Surgery Partners in a research report on Monday, August 26th. Get Our Latest Stock Analysis on SGRY Surgery Partners Price Performance Surgery Partners ( NASDAQ:SGRY – Get Free Report ) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.
21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01.
The firm had revenue of $762.10 million for the quarter, compared to analysts’ expectations of $735.94 million.
Surgery Partners had a positive return on equity of 2.96% and a negative net margin of 1.17%.
The company’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.
25 EPS. Equities research analysts expect that Surgery Partners will post 0.86 EPS for the current year.
Institutional Inflows and Outflows A number of hedge funds have recently modified their holdings of the stock. Janus Henderson Group PLC lifted its stake in shares of Surgery Partners by 7,987.1% in the first quarter.
Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after acquiring an additional 2,473,282 shares during the period. Deerfield Management Company L.P.
Series C lifted its stake in shares of Surgery Partners by 47.7% in the second quarter. Deerfield Management Company L.
P. Series C now owns 4,707,287 shares of the company’s stock worth $111,986,000 after acquiring an additional 1,520,484 shares during the period. Point72 Asset Management L.
P. acquired a new position in shares of Surgery Partners in the second quarter worth approximately $29,288,000. Iron Triangle Partners LP acquired a new position in shares of Surgery Partners in the fourth quarter worth approximately $33,415,000.
Finally, Norges Bank acquired a new position in shares of Surgery Partners in the fourth quarter worth approximately $25,765,000. About Surgery Partners ( Get Free Report Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Read More Five stocks we like better than Surgery Partners Stock Average Calculator Simon Property REIT: A Safe Bet for Growth and Steady Dividends Business Services Stocks Investing CarMax’s Impressive Rally: What Investors Should Watch Next 3 Warren Buffett Stocks to Buy Now MarketBeat Week in Review – 9/23 – 9/27 Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter ..
